ClinicalEffect of QRS area reduction and myocardial scar on the hemodynamic response to cardiac resynchronization therapy
Graphical abstract
Introduction
Cardiac resynchronization therapy (CRT) is an established therapy for patients with impaired left ventricular (LV) systolic function and a wide QRS complex. In addition to improving symptoms and quality of life, CRT reduces heart failure hospitalizations and improves survival.1 However, even in guideline-indicated patients, the response to CRT is variable. The nonresponder rate ranges between 9% and 68%, depending on the criteria used to define response.2 Prominent among the factors implicated in nonresponse is suboptimal LV lead deployment.
Quadripolar LV leads (QUAD) have been a game-changer in the field of CRT. The availability of a wide range of left ventricular pacing locations (LVPLs) not only reduces diaphragmatic stimulation but also permits LV pacing from widely spaced areas of the myocardium. Several studies have shown that optimizing LVPLs on a QUAD in individual patients improves the acute hemodynamic response (AHR) to CRT.3,4 Myocardial scar in the vicinity of the LVPL has been shown to be detrimental in studies using bipolar leads,5,6 but no studies have explored whether the same applies to QUAD.
It has been shown recently that vectorcardiography (VCG)-derived QRS area (QRSarea) is a measure of LV electrical dyssynchrony, the natural substrate of CRT.7 Moreover, QRSarea has been shown to correlate with AHR8,9 and LV reverse remodeling10 after CRT. A reduction in QRSarea has been shown to improve AHR to CRT in patients with suboptimal LV lead deployment.11 Importantly, preimplant QRSarea has been shown to be superior to QRS duration (QRSd) in predicting total mortality after CRT.12,13 We recently showed that a postimplant reduction in both QRSarea and QRSd was associated with the best outcomes after CRT.14 In the present study, we explored whether in patients with an optimally deployed LV lead assessed by fluoroscopy, a change in QRSarea (ΔQRSarea) after CRT relates to AHR; AHR in individual patients can be improved by reducing QRSarea; and AHR relates to the position of the LVPL in relation to myocardial scar, assessed using cardiac magnetic resonance (CMR).
Section snippets
Methods
A total of 26 patients referred for CRT implantation at the University Hospital Birmingham, United Kingdom, were studied. All patients provided written informed consent. The study was approved by the regional ethics committee and conformed with the Declaration of Helsinki.
Baseline characteristics
A total of 4 of 30 patients (13.3%) who had been enrolled were excluded because of second-degree atrioventricular block during atrial (AAI) pacing in 1; frequent ventricular ectopics in 1; and LV thrombus noted on CMR in 2. Among the 26 patients included (age 69 ± 9.1 years; 20/26 [77%] male), the underlying etiology was ICM in 17 (65%) (Table 1). Left bundle branch block (LBBB) was present in 20 patients (76.9%) and non-LBBB in 6 (23.1%) (5 nonspecific intraventricular conduction delay; 1
Discussion
Several findings have emerged regarding the optimization of LVPLs in CRT recipients who have a fluoroscopically ideal LV lead position. First, altering LVPLs on a QUAD was associated with wide intraindividual variations in LV dP/dtmax, QRSarea, and QRSd. Second, ΔQRSarea correlated with ΔLV dP/dtmax across LVPLs. Third, both myocardial scar burden and location of scar in the vicinity of the LVPL had a negative effect on AHR to CRT.
Conclusion
We have shown that in patients with an ideally deployed LV lead, optimizing LVPLs on a QUAD to achieve maximum QRSarea reduction leads to the best AHR to CRT. Both myocardial scar burden and location of scar in the vicinity of the LVPL had a negative effect on AHR to CRT. These findings have implications for the use of QRSarea and CMR in CRT optimization.
References (21)
- et al.
20 years of cardiac resynchronization therapy
J Am Coll Cardiol
(2014) - et al.
Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
J Cardiovasc Magn Reson
(2011) - et al.
Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: a prospective, single-centre randomized study (CMR-CRT)
Int J Cardiol
(2018) - et al.
Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by electroanatomic mapping in candidates for cardiac resynchronization therapy
Heart Rhythm
(2016) - et al.
Vectorcardiographic QRS area as a novel predictor of response to cardiac resynchronization therapy
J Electrocardiol
(2015) - et al.
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
J Am Coll Cardiol
(2006) - et al.
Relationship between vectorcardiographic QRSarea, myocardial scar quantification, and response to cardiac resynchronization therapy
J Electrocardiol
(2018) - et al.
Scar tissue-guided left ventricular lead placement for cardiac resynchronization therapy in patients with ischemic cardiomyopathy: an acute pressure-volume loop study
Am Heart J
(2014) - et al.
Agreement is poor among current criteria used to define response to cardiac resynchronization therapy
Circulation
(2010) - et al.
Haemodynamic effects of cardiac resynchronization therapy using single-vein, three-pole, multipoint left ventricular pacing in patients with ischaemic cardiomyopathy and a left ventricular free wall scar: the MAESTRO study
Europace
(2016)
Cited by (0)
Funding sources: There are no funding sources other than those listed in Disclosures below.
Disclosures: Dr Okafor was supported by an unrestricted educational grant from Medtronic Plc. Dr van Dam is owner of PEACS. Dr Leyva has received consulting fees and research sponsorship from Medtronic Plc, Boston Scientific, Abbott, Biotronik, and Microport. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.